
    
      The objective of this study is to evaluate the human bioequivalence of Venlafaxine
      Hydrochloride Sustained-Release Capsules (75 mg) produced by Beijing Winsunny Pharmaceutical
      Co., Ltd and EFEXORÂ® XR (75mg) produced by Pfizer Ireland Pharmaceuticals(held by Pfizer
      Healthcare Ireland, distributed by Wyeth pharmaceutical co. LTD), as well as the safety of
      the tested preparation, and to provide basis for the evaluation of the quality and efficacy
      consistency of the tested preparation and the reference preparation.
    
  